2017-03-20,Alkermes To Present Data On Two-Month Dosing Option Of ARISTADA® At 16th International Congress On Schizophrenia Research
2017-03-16,Alkermes Initiates Phase 3 Gastrointestinal Tolerability Study Of ALKS 8700 For Treatment Of Multiple Sclerosis
2017-03-08,The 'Gnarly 9' Biotechs Will Test the FDA's Mettle
2017-03-08,Could These 9 Drugs Gain FDA Approval in the Age of Trump?
2017-03-08,The 'Gnarly 9' Biotechs Will Test the FDA's Mettle
2017-03-07,Alkermes' Corporate Presentation To Be Webcast At The Barclays Global Healthcare Conference
2017-02-28,Alkermes' Corporate Presentation To Be Webcast At The Cowen And Company 37th Annual Health Care Conference
2017-02-16,Ratings Changes Today
2017-02-15,Alkermes Plc Reports Financial Results For The Year Ended Dec. 31, 2016 And Provides Financial Expectations For 2017
2017-02-08,Alkermes To Host Conference Call To Discuss Fourth Quarter And Year-End 2016 Financial Results
2017-01-06,Health Care, Banks Lead Game Strategy for Next Week: Cramer's 'Mad Money' Recap (Friday 1/6/17)
2017-01-03,Alkermes' Corporate Presentation To Be Webcast At The 35th Annual J.P. Morgan Healthcare Conference
2016-11-28,Short Interest Makes 14% Move For ALKS
2016-11-15,Alkermes (ALKS) CEO Pops Says Biotech Stocks 'Recovered Quite a Bit' Post-Election
2016-11-09,Alkermes' Corporate Presentation To Be Webcast At The Jefferies 2016 London Healthcare Conference
2016-11-03,ALKERMES Inspiration Grants™ Awarded To Support People Affected By Mental Health And Substance Use Disorders
2016-11-02,Alkermes Plc Reports Third Quarter 2016 Financial Results
2016-11-01,Alkermes' Corporate Presentation To Be Webcast At The Credit Suisse 25th Annual Healthcare Conference
2016-10-27,Jim Cramer's Top Takeaways: Norfolk Southern, Apple, Snap-On
2016-10-26,Jim Cramer's 'Mad Money' Recap: Demand and Takeover Talk Lift Stocks
2016-10-26,Alkermes To Host Conference Call To Discuss Third Quarter 2016 Financial Results
2016-10-24,Bullish and Bearish Reversals for the Week
2016-10-21,A Democratic Sweep?; M&amp;A Just the Beginning: Jim Cramer's Best Blogs
2016-10-21,Jim Cramer's 'Mad Money' Recap: Takeover Talk Distracts From Earnings Focus
2016-10-21,Alkermes (ALKS) Stock Soars on Trial Results, Upgrades
2016-10-21,Cramer: M&amp;A Is Just the Beginning of Today's Story
2016-10-21,Analysts' Actions -- Alkermes, Chesapeake, Microsoft, Yahoo! and More
2016-10-20,Alkermes Depression Drug Finds Success on Third Study Attempt
2016-10-20,Alkermes Announces Positive Topline Results From FORWARD-5 Pivotal Phase 3 Study Of ALKS 5461 For Major Depressive Disorder
2016-10-03,Alkermes Announces Initiation Of Clinical Study Evaluating Metabolic Profile Of ALKS 3831 For Treatment Of Schizophrenia
2016-09-27,Jim Cramer -- Gilead Needs to Make an Acquisition
2016-09-19,Alkermes Announces Webcast Of Analyst And Investor Event On September 26, 2016
2016-09-12,ALKERMES™ Inspiration Grants Application
2016-09-06,Alkermes' Corporate Presentation To Be Webcast At The Morgan Stanley Global Healthcare Conference
2016-08-15,Want a Dash for Trash? Why Not Look at Alkermes
2016-08-08,Alkermes Submits Supplemental New Drug Application To FDA For Two-Month Dosing Option Of ARISTADA® For Treatment Of Schizophrenia
2016-07-29,Alkermes (ALKS) Is Today's Dead Cat Bounce Stock
2016-07-28,Water-Logged And Getting Wetter: Alkermes (ALKS)
2016-07-28,Alkermes Plc Reports Second Quarter 2016 Financial Results
2016-07-27,Jim Cramer's Top Takeaways: Acacia Communications, KeyCorp, Alkermes
2016-07-26,Jim Cramer's 'Mad Money' Recap: 'Good Enough' Is a Triumph
2016-07-21,Alkermes To Host Conference Call To Discuss Second Quarter 2016 Financial Results
2016-06-01,Alkermes' Corporate Presentation To Be Webcast At The Goldman Sachs 37th Annual Global Healthcare Conference
2016-05-26,Alkermes Appoints Nancy Snyderman, M.D., To Board Of Directors
2016-05-25,Alkermes Announces Initiation Of Phase 1 Clinical Study Of Immuno-Oncology Drug Candidate ALKS 4230
2016-05-24,Alkermes To Present Data On ALKS 5461 At Upcoming American Society Of Clinical Psychopharmacology Annual Meeting
2016-04-28,Alkermes Plc Reports First Quarter 2016 Financial Results
2016-04-28,Alkermes Announces Plan To Initiate Second Clinical Trial Of ALKS 7119 Based On Preliminary Phase 1 Results
2016-04-21,Alkermes To Host Conference Call To Discuss First Quarter 2016 Financial Results
2016-04-14,Stalking a Speculative Trade in Alkermes
2016-03-31,Buy Acadia, Alkermes, Starbucks and Verizon, Says Mott Capital Portfolio Manager
2016-03-31,Should Acadia, Alkermes Shares be at the Top of Your Buy List?
2016-03-31,Study On Extended-Release Naltrexone In Opioid-Dependent Patients Involved In Criminal Justice System Published In The New England Journal Of Medicine
2016-03-28,Alkermes To Present Data On Schizophrenia Portfolio At Upcoming Schizophrenia International Research Society Conference
2016-03-09,Alkermes' Corporate Presentation To Be Webcast At The Barclays Global Healthcare Conference
2016-03-09,Weak On High Volume: Alkermes (ALKS)
2016-03-07,Insider Trading Alert - HAFC, ALKS And PRGO Traded By Insiders
2016-03-04,Trade-Ideas: Alkermes (ALKS) Is Today's Post-Market Leader Stock
2016-03-01,Alkermes' Corporate Presentation To Be Webcast At The Cowen And Company 36th Annual Health Care Conference
2016-02-25,Feb. 25 Premarket Briefing: 10 Things You Should Know
2016-02-25,Alkermes Plc Reports Financial Results For The Year Ended Dec. 31, 2015 And Provides Financial Expectations For 2016
2016-02-25,Alkermes Announces Positive Topline Results From Clinical Study Of Two-Month Dosing Option Of ARISTADA® For Treatment Of Schizophrenia
2016-02-19,Alkermes (ALKS) Is Today's Dead Cat Bounce Stock
2016-02-18,Alkermes To Host Conference Call To Discuss Fourth Quarter And Year-End 2015 Financial Results
2016-02-12,5 Breakout Stocks to Trade for Big Gains
2016-02-11,Short Interest In Alkermes Drops 16%
2016-02-10,Alkermes Announces Initiation Of Second Phase 3 Study Of ALKS 3831 For Schizophrenia
2016-02-02,Alkermes' Corporate Presentation To Be Webcast At Two Upcoming Conferences
2016-01-25,Alkermes Announces Initiation Of Phase 1 Clinical Study Of New CNS Drug Candidate ALKS 7119
2016-01-24,8 Things That Could Lift Biotech Stocks Out of Bear Market
2016-01-21,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Involving Possible Violations Of Federal Securities Laws By The Board Of Alkermes Plc
2016-01-21,3 Drugs Stocks Dragging The Industry Down
2016-01-21,Jim Cramer -- Alkermes Is a Big Disappointment Today
2016-01-21,Analysts Split On Alkermes After Depression Trials Fail
2016-01-21,Alkermes (ALKS) Stock Plunges on Depression Treatment's Trial Results
2016-01-21,Alkermes Depression Drug Failure Crimps Future Growth Outlook
2016-01-21,Trade-Ideas: Alkermes (ALKS) Is Today's Pre-Market Mover With Heavy Volume Stock
2016-01-21,Alkermes Announces Topline Results Of FORWARD-3 And FORWARD-4, Two Phase 3 Studies Of ALKS 5461 In Major Depressive Disorder
2016-01-20,Weak On High Volume: Alkermes (ALKS)
2016-01-12,Alkermes (ALKS) Showing Signs Of Being Water-Logged And Getting Wetter
2016-01-05,Alkermes' Corporate Presentation To Be Webcast At The 34th Annual J.P. Morgan Healthcare Conference
2016-01-05,2016 Stock Picks From Mott Capital: Alkermes, Tesla, Disney, More
2016-01-05,Alkermes, Tesla & Disney Shares Set for Strong 2016 Performances
2016-01-04,Alkermes (ALKS) Is Today's Water-Logged And Getting Wetter Stock
2015-12-26,Sell These 6 Biotech Stocks Now Before It's Too Late
2015-12-16,Alkermes Announces Achievement Of Milestones For CNS Medicines In Proprietary Product And Pipeline Portfolio
2015-12-02,3 Stocks Raising The Health Care Sector Higher
2015-11-17,Jim Cramer's 'Mad Money' Recap: Why Good News Is Bad News in This Market
2015-11-17,Trade-Ideas: Alkermes (ALKS) Is Today's Post-Market Leader Stock
2015-11-16,No Snake Oil in These Four Pharmaceutical Stocks
2015-11-11,Alkermes' Corporate Presentation To Be Webcast At The Jefferies 2015 London Healthcare Conference
2015-11-05,Insider Trading Alert - ALKS, REIS And LAD Traded By Insiders
2015-11-04,Retrophin Sinks, Pharma Group Swings Back As Pricing Fight Escalates
2015-11-03,Alkermes' Corporate Presentation To Be Webcast At The Credit Suisse 24Th Annual Healthcare Conference
2015-10-29,Alkermes Plc Reports Third Quarter 2015 Financial Results
2015-10-29,Alkermes Announces Positive Clinical Trial Results And Streamlined Registration Pathway For ALKS 8700 For Treatment Of Multiple Sclerosis
2015-10-23,Alkermes (ALKS) Flagged As Strong On High Volume
2015-10-22,Alkermes To Host Conference Call To Discuss Third Quarter 2015 Financial Results
2015-10-08,Jim Cramer's Top Takeaways: Alkermes, Yum! Brands, Novocure
2015-10-07,Jim Cramer's 'Mad Money' Recap: Watching China Warily, Again
2015-10-07,Alkermes (ALKS) Stock Price Target Upped at Barclays
2015-10-07,Early Warning Signs Of Schizophrenia Are Not Acted On Soon Enough, According To New Survey Of Psychiatrists And Caregivers
2015-10-06,Insider Trading Alert - ALKS, ED And TRC Traded By Insiders
2015-10-05,ARISTADA™ Product Image. Please see Important Safety Information, including Boxed Warning, below and accompanying full Prescribing Information. (Photo: Business Wire)
2015-10-02,Morgan Stanley Says These 9 Health Care Stocks Are Best-Positioned, Despite Rising Drug Prices
2015-09-30,Alkermes (ALKS) Strong On High Relative Volume Today
2015-09-24,Alkermes (ALKS) Marked As Today's Roof Leaker Stock
2015-09-22,Analysts Say Buy Select Biotech Stocks Ahead Of Clinton Drug Plan
2015-09-10,Alkermes' Corporate Presentation To Be Webcast At The Morgan Stanley Global Healthcare Conference
2015-09-03,Insider Trading Alert - GMCR, ALKS And INUV Traded By Insiders
2015-09-01,Today's Dead Cat Bounce Stock Is Alkermes (ALKS)
2015-09-01,New Ratings on American Airlines, Delta and 8 Other Stocks -- Analysts' Actions
2015-08-28,Credit Suisse's 8 Pharmaceutical Stocks With 'Significant' Upside
2015-08-21,Alkermes Provides Update On FDA Review Of ARISTADA™ For The Treatment Of Schizophrenia
2015-07-30,Alkermes Plc Reports Second Quarter 2015 Financial Results
2015-07-23,Alkermes To Host Conference Call To Discuss Second Quarter 2015 Financial Results
2015-07-03,Insider Trading Alert - BXMT, ALKS And FRME Traded By Insiders
2015-06-18,Jim Cramer's Top Takeaways: Palo Alto Networks, Tesla, Ambarella, Allergan, Wingstop, Alkermes
2015-06-17,Jim Cramer's 'Mad Money' Recap: Thanks for Nothing, Janet Yellen
2015-06-16,Alkermes (ALKS) Stock Gains After Announcing Presentation at Annual ASCP Meeting
2015-06-16,Strong On High Relative Volume: Alkermes (ALKS)
2015-06-16,Alkermes To Present Data From Late-Stage CNS Portfolio At Upcoming American Society Of Clinical Psychopharmacology Annual Meeting
2015-06-09,Aripiprazole Lauroxil Phase 3 Schizophrenia Study Results Published In Journal Of Clinical Psychiatry
2015-06-02,Alkermes' Corporate Presentation To Be Webcast At The Goldman Sachs 36th Annual Global Healthcare Conference
2015-06-02,Insider Trading Alert - ALKS, CUBI And WLFC Traded By Insiders
2015-05-29,Alkermes To Present Clinical Data On ALKS 8700 At Annual Meeting Of The Consortium Of Multiple Sclerosis Centers
2015-05-26,Alkermes' Corporate Presentation To Be Webcast At The Jefferies 2015 Global Healthcare Conference
2015-05-11,Alkermes' Corporate Presentation To Be Webcast At The UBS Global Healthcare Conference
2015-04-30,Alkermes Plc Reports First Quarter 2015 Financial Results
2015-04-23,Alkermes To Host Conference Call To Discuss First Quarter 2015 Financial Results
2015-04-13,Alkermes To Present Preclinical Data On Novel Selective Effector Cell Activator (SECA™) Immuno-Oncology Candidate At Upcoming American Association For Cancer Research Annual Meeting
2015-04-06,Alkermes Announces Positive Topline Results From Complete Six-Month Phase 2 Clinical Trial Of ALKS 3831 In Schizophrenia
2015-03-23,Alkermes To Present Data On Aripiprazole Lauroxil And ALKS 3831 At 15th International Congress On Schizophrenia Research
2015-03-12,Analysts' Actions: Alkermes, GNC, Hewlett-Packard and More
2015-03-09,Alkermes Plc Announces Sale Of Gainesville, GA Manufacturing Facility To Recro Pharma, Inc.
2015-03-07,Value in Good Management; Biotechs Are Feeling Better: Jim Cramer's Best Blogs
2015-03-05,Trade-Ideas: Alkermes (ALKS) Is Today's Strong On High Relative Volume Stock
2015-03-04,Jim Cramer's 'Mad Money' Recap: The Market Is a Battlefield
2015-03-04,Alkermes Plc (ALKS) Downgraded From Hold to Sell
2015-03-03,Alkermes' Corporate Presentation To Be Webcast At The Barclays Global Healthcare Conference
2015-03-03,Ratings Changes Today
2015-03-02,Alkermes Announces New Drug Candidate, ALKS 7119, For Treatment Of Alzheimer's Agitation, Depression And Other CNS Diseases
2015-02-24,Alkermes' Corporate Presentation To Be Webcast At The Cowen And Company 35th Annual Health Care Conference
2015-02-24,Jim Cramer: Use Share Weakness to Buy Alkermes for Its Drug Pipeline
2015-02-24,Alkermes Plc Reports Financial Results For The Year Ended Dec. 31, 2014 And Provides Financial Expectations For 2015
2015-02-24,Alkermes Announces Results From Phase 1 Study Of ALKS 7106
2015-02-23,Alkermes Announces Webcast Of Analyst And Investor Event On March 2, 2015
2015-02-23,Alkermes Appoints Mark Namchuk, Ph.D., As Senior Vice President Of Research, Pharmaceutical And Nonclinical Development
2015-02-17,Alkermes To Host Conference Call To Discuss Fourth Quarter And Year-End 2014 Financial Results
2015-02-11,Jim Cramer's Top Stock Picks: GM HAS SAVE ALKS
2015-02-10,Jim Cramer's 'Mad Money' Recap: No Foreign News Is Great U.S. News
2015-02-09,Alkermes Announces Positive Topline Results From Phase 1 Study Of ALKS 8700 For Treatment Of Multiple Sclerosis
2015-02-03,Alkermes' Corporate Presentation To Be Webcast At Two Upcoming Conferences
2015-01-07,Jim Cramer Says Alkermes Shares Are Going 'Much Higher'
2015-01-07,Alkermes CEO: Our Proprietary Drug Pipeline Is 'Maturing Beautifully'
2015-01-07,Alkermes Announces Positive Results Of Phase 2 Clinical Trial Of ALKS 3831 In Schizophrenia
2015-01-06,Alkermes' Corporate Presentation To Be Webcast At The 33rd Annual J.P. Morgan Healthcare Conference
2015-01-06,Jim Cramer: Why Are You Shorting Innovative Biotech Stocks?
2015-01-06,Alkermes Announces Positive Results From Study Of ALKS 5461 For Treatment Of Major Depressive Disorder
2014-12-15,Alkermes Announces Initiation Of Clinical Study Of Extended Durations Of Aripiprazole Lauroxil For Treatment Of Schizophrenia
2014-11-25,Alkermes' Corporate Presentation To Be Webcast At The NASDAQ OMX 31st Investor Program
2014-11-19,Jim Cramer's Top Stock Picks: MMM UNH CELG AMZN HD ALKS PPG
2014-11-18,Jim Cramer's 'Mad Money' Recap: Why Running With the Bulls Is Profitable but Dangerous
2014-11-04,Alkermes' Corporate Presentation To Be Webcast At The Credit Suisse 2014 Healthcare Conference
2014-10-29,Alkermes Plc Reports Third Quarter 2014 Financial Results
2014-10-22,Alkermes To Host Conference Call To Discuss Third Quarter 2014 Financial Results
2014-10-22,Alkermes’ New Drug Application For Aripiprazole Lauroxil For Treatment Of Schizophrenia Accepted For Filing By U.S. FDA
2014-09-16,'Mad Money' Lightning Round: Buy, Buy, Buy St Jude Medical
2014-09-15,Jim Cramer's 'Mad Money' Recap: Time to Make Room for Alibaba
2014-09-03,Alkermes Announces Completion Of Patient Enrollment In Phase 2 Study Of ALKS 3831, A Novel, Broad-Spectrum Oral Antipsychotic
2014-09-02,Alkermes’ Corporate Presentation To Be Webcast At The Morgan Stanley Global Healthcare Conference
2014-08-26,Alkermes Announces Initiation Of Phase 1 Clinical Study Of ALKS 7106 For Treatment Of Pain
2014-08-25,Alkermes Submits New Drug Application To FDA For Aripiprazole Lauroxil For Treatment Of Schizophrenia
2014-07-31,Alkermes Plc Reports Second Quarter 2014 Financial Results
2014-07-30,Alkermes Announces Initiation Of FORWARD-5 Clinical Study Of ALKS 5461 For Treatment Of Major Depressive Disorder
2014-07-24,Alkermes To Host Conference Call To Discuss Second Quarter 2014 Financial Results
2014-07-17,Alkermes Announces Initiation Of Phase 1 Clinical Study Of ALKS 8700 For Treatment Of Multiple Sclerosis
2014-07-09,Alkermes Announces Notices Of Allowance For U.S. Patents For Four CNS Pipeline Candidates
2014-07-01,Alkermes Moves Up In Market Cap Rank, Passing Iron Mountain
2014-06-18,Alkermes Presents Phase 3 Data From Successful Pivotal Study Of Aripiprazole Lauroxil For Treatment Of Schizophrenia At ASCP Annual Meeting
